Bovenden, Germany

Alexander Zilaev

This inventor holds 1 USPTO granted patent. Top assignee: Sartorius Stedim Biotech Gmbh. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Zilaev: Innovator in Bioprocessing Technology

Introduction

Alexander Zilaev is a notable inventor based in Bovenden, Germany. He has made significant contributions to the field of bioprocessing technology. His innovative work has led to the development of a unique bioprocessing installation that enhances the efficiency of biological medium transfer.

Latest Patents

Zilaev holds a patent for a bioprocessing installation that includes a reservoir tank, fluid lines, receiving containers, and an electronic control unit. This installation allows for the effective transfer of liquid biological medium from the reservoir tank to the receiving containers. The system is equipped with a sensor arrangement that detects gas bubbles or foam in the medium, ensuring optimal monitoring and control during the transfer process.

Career Highlights

Zilaev is currently employed at Sartorius Stedim Biotech GmbH, a leading company in the biotech industry. His role involves the application of his patented technology to improve bioprocessing methods. His expertise in this area has positioned him as a valuable asset to his team and the company.

Collaborations

Zilaev collaborates with talented professionals such as Matthias Bode and Swen Weitemeier. Together, they work on advancing bioprocessing technologies and enhancing the capabilities of their products.

Conclusion

Alexander Zilaev's contributions to bioprocessing technology through his innovative patent demonstrate his commitment to improving biological processes. His work at Sartorius Stedim Biotech GmbH and collaborations with skilled colleagues further highlight his impact in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…